PMID: 9359528Nov 14, 1997

Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor

British Journal of Haematology
T FurukawaY Aizawa

Abstract

Primary familial and congenital polycythaemia (PFCP) is a rare disease characterized by congenital erythrocytosis inherited in an autosomal dominant fashion. Recently, mutations in the erythropoietin receptor (EpoR) have been identified in PFCP families. We describe a Japanese family with an autosomal dominant inheritance of PFCP. An in vitro colony assay demonstrated hypersensitivity of erythroid progenitors to erythropoietin (Epo) in affected family members. Sequence analysis of RT-PCR products amplified from the C-terminal region of EpoR transcripts in affected family members revealed that they were all heterozygous for C and T bases at position 5986, which suggested a genetic mutation (C to T) on one allele of EpoR. This mutation gave rise to a translation termination codon TAG at amino acid 435. Thus, the resulting EpoR is a truncated protein product lacking all 74 amino acids downstream of the mutation. To date, all genetic mutations affecting a family with PFCP, including this one, have been located in the cytoplasmic negative regulatory region of the EpoR. All mutations gave rise to truncated Epo receptors between Tyrosine 427 and Tyrosine 455. The phosphotyrosines in this region of EpoR have been demonstrated to be bin...Continue Reading

Citations

Mar 26, 2011·International Journal of Hematology·Kacey O'RourkeGlen A Kennedy
Aug 30, 2000·Domestic Animal Endocrinology·P L PearsonJ L Vallet
Nov 28, 2001·European Journal of Haematology·T MotohashiH Nakauchi
Feb 14, 2002·British Journal of Haematology·Farhad RavandiZeev Estrov
Feb 17, 2000·Current Opinion in Pediatrics·R Kralovics, J T Prchal
Jun 26, 2004·Journal of Pediatric Hematology/oncology·Tom Van MaerkenJoris Verlooy
Nov 21, 2007·Hematology·Radek Skoda
Aug 1, 2012·Biologics : Targets & Therapy·Steve Elliott, Angus M Sinclair
Oct 1, 2008·International Journal of Laboratory Hematology·Mary Frances McMullin
May 20, 2008·Hematological Oncology·Elisa Rumi
Aug 21, 2013·Journal of Cellular Biochemistry·Christopher J Carbone, Serge Y Fuchs
Jan 26, 2010·British Journal of Haematology·Lily J HuangGamze B Bulut
Oct 12, 2013·Human Mutation·Celeste BentoECE-Consortium
Jan 20, 2000·Baillière's Clinical Haematology·A J BenchA R Green
Oct 8, 2005·Seminars in Hematology·Radek Skoda, J T Prchal
Jan 24, 2003·Expert Opinion on Therapeutic Targets·Linda Hibbert, James A Johnston
Mar 6, 1998·British Journal of Haematology·M J PercyT C Pearson
Apr 30, 2014·JAK-STAT·Frank-D Böhmer, Karlheinz Friedrich
Sep 18, 2001·American Journal of Hematology·R Kralovics, J T Prchal
Jan 12, 1999·American Journal of Hematology·M F McMullin, M J Percy
Mar 20, 2009·Leukemia·M M Patnaik, A Tefferi

Related Concepts

Genealogical Tree
Erythrocytosis
Erythroid Progenitor Cells
Nested Polymerase Chain Reaction
Point Mutation
Erythropoietin Receptor

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.